SEC 13F Intelligence

Managers / Q1 2019 · view latest →

TradeLink Capital LLC

CIK 0001642044 · 71 S. WACKER DR., SUITE 1900, CHICAGO, IL, 60606 · 312-264-2196

Reported Value
$19M
Q1 2019
Positions
33
Filings on Record
31
2019–present window
Filed
Apr 25, 2019
original filing

Summary

Tradelink Capital LLC reported $19M in U.S.-listed holdings across 33 positions for Q1 2019.

The portfolio is heavily concentrated: COTY alone accounts for 24.4% of reported value.

Portfolio Metrics

Top-10 Concentration
+64.1%
share of reported value
Largest Position
+24.4%
Coty

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q1 ’19: $19MQ1 ’19Q2 ’19: $7MQ3 ’19: $14MQ4 ’19: $3MQ1 ’20: $3MQ1 ’20Q2 ’20: $24MQ3 ’20: $5MQ4 ’20: $314,000Q1 ’21: $7MQ1 ’21Q2 ’21: $4MQ3 ’21: $12MQ4 ’21: $527,000Q1 ’22: $22MQ1 ’22Q2 ’22: $4MQ3 ’22: $5MQ4 ’22: $4,642Q2 ’23: $3MQ2 ’23Q3 ’23: $3,227Q4 ’23: $7MQ1 ’24: $7MQ2 ’24: $35MQ2 ’24Q1 ’25: $16MQ2 ’25: $28MQ3 ’25: $14MQ4 ’25: $13MQ4 ’25Q1 ’26: $13Mfilingsflow.com

Portfolio Composition

By security type
Common Stock: 61.5%Other: 28.6%REIT: 6.1%ETP: 3.8%
  • Common Stock · 61.5% · $12M
  • Other · 28.6% · $5M
  • REIT · 6.1% · $1M
  • ETP · 3.8% · $712,000

Quarter-over-Quarter Changes full breakdown →

IssuerMoveShare ΔShares nowValue ΔValue now
VANECK VECTORS ETF TRNEW+250250+$3M$3M
COTYCOTY INCNEW+200.0K200.0K+$2M$2M
COTY INCNEW+2.0K2.0K+$2M$2M
DISDISNEY WALT CONEW+8.9K8.9K+$988,000$988,000
VANECK VECTORS ETF TRNEW+41.3K41.3K+$712,000$712,000
TWLOTWILIO INCNEW+3.8K3.8K+$491,000$491,000
ZBRAZEBRA TECHNOLOGIES CORPNEW+2.2K2.2K+$461,000$461,000
STESTERIS PLCNEW+3.4K3.4K+$435,000$435,000

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q1 2019

31 positions (from 33 filing rows — )
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1COTYCOTY INCPUT · COM CL A24.45%$5M202.0K
2VANECK VECTORS ETF TRPUT · OIL SVCS ETF18.06%$3M41.5K
3DISDISNEY WALT COhistory →COM DISNEY5.25%$988,0008.9K
4TWLOTWILIO INChistory →CL A2.61%$491,0003.8K
5ZBRAZEBRA TECHNOLOGIES CORPhistory →CL A2.45%$461,0002.2K
6STESTERIS PLChistory →SHS USD2.31%$435,0003.4K
7EXKEXACT SCIENCES CORPhistory →COM2.30%$433,0005.0K
8RVTYPERKINELMER INChistory →COM2.25%$424,0004.4K
9IONSIONIS PHARMACEUTICALS INChistory →COM2.24%$422,0005.2K
10SUISUN CMNTYS INChistory →COM2.14%$403,0003.4K
11FDSFACTSET RESH SYS INChistory →COM2.11%$397,0001.6K
12ULTIMATE SOFTWARE GROUP INCCOM2.10%$396,0001.2K
13MKTXMARKETAXESS HLDGS INChistory →COM2.09%$394,0001.6K
14ELSEQUITY LIFESTYLE PPTYS INChistory →COM2.07%$389,0003.4K
15PAYCPAYCOM SOFTWARE INChistory →COM2.01%$378,0002.0K
16ZENDESK INCCOM1.99%$374,0004.4K
17VICIVICI PPTYS INChistory →COM1.90%$357,00016.3K
18SNAPSNAP INChistory →CL A1.89%$356,00032.3K
19OKTAOKTA INChistory →CL A1.84%$347,0004.2K
20BLUEBIRD BIO INCCOM1.84%$346,0002.2K
21EPAMEPAM SYS INChistory →COM1.80%$338,0002.0K
22SRPTSAREPTA THERAPEUTICS INChistory →COM1.78%$334,0002.8K
23TDYTELEDYNE TECHNOLOGIES INChistory →COM1.76%$332,0001.4K
24SAGE THERAPEUTICS INCCOM1.69%$318,0002.0K
25RNGRINGCENTRAL INChistory →CL A1.61%$302,0002.8K
26HEI/AHEICO CORP NEWhistory →CL A1.34%$252,0003.0K
27BHFBRIGHTHOUSE FINL INChistory →COM1.33%$250,0006.9K
28BIOBIO RAD LABS INChistory →CL A1.30%$245,000800
29MDBMONGODB INChistory →CL A1.25%$235,0001.6K
30ROKUROKU INChistory →COM CL A1.13%$213,0003.3K
31DOCUDOCUSIGN INChistory →COM1.10%$207,0004.0K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2026$13M34May 13, 202613F-HRchanges · EDGAR ↗
Q4 2025$13M27Feb 4, 202613F-HRchanges · EDGAR ↗
Q3 2025$14M31Nov 3, 202513F-HRchanges · EDGAR ↗
Q2 2025$28M51Aug 13, 202513F-HRchanges · EDGAR ↗
Q1 2025$16M40May 8, 202513F-HRchanges · EDGAR ↗
Q4 2024Under review26Feb 7, 202513F-HRchanges · EDGAR ↗
Q3 2024Under review1Nov 12, 202413F-HRchanges · EDGAR ↗
Q2 2024$35M88Aug 8, 202413F-HRchanges · EDGAR ↗
Q1 2024$7M21May 13, 202413F-HRchanges · EDGAR ↗
Q4 2023$7M19Feb 13, 202413F-HRchanges · EDGAR ↗
Q3 2023$3,2272Nov 9, 202313F-HRchanges · EDGAR ↗
Q2 2023$3M10Aug 11, 202313F-HRchanges · EDGAR ↗
Q4 2022$4,6422Feb 13, 2023RESTATEMENTchanges · EDGAR ↗
Q3 2022$5M4Nov 8, 202213F-HRchanges · EDGAR ↗
Q2 2022$4M1Aug 9, 202213F-HRchanges · EDGAR ↗
Q1 2022REVEALED$22M32May 10, 202213F-HRchanges · EDGAR ↗
Q4 2021$527,0002Jan 27, 202213F-HRchanges · EDGAR ↗
Q3 2021$12M4Oct 29, 202113F-HRchanges · EDGAR ↗
Q2 2021$4M1Aug 10, 202113F-HRchanges · EDGAR ↗
Q1 2021$7M15May 7, 202113F-HRchanges · EDGAR ↗
Q4 2020$314,0002Feb 1, 202113F-HRchanges · EDGAR ↗
Q3 2020$5M5Nov 2, 202013F-HRchanges · EDGAR ↗
Q2 2020$24M53Jul 29, 202013F-HRchanges · EDGAR ↗
Q1 2020$3M2May 11, 202013F-HRchanges · EDGAR ↗
Q4 2019$3M6Feb 10, 202013F-HRchanges · EDGAR ↗
Q3 2019$14M24Oct 28, 201913F-HRchanges · EDGAR ↗
Q2 2019$7M10Jul 31, 201913F-HRchanges · EDGAR ↗
Q1 2019$19M33Apr 25, 201913F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.